UBS Group’s ETRACS 2x Leveraged US Growth Factor TR ETN IWFL Stock Holding History

UBS Group’s Portfolio IWFL Stock Details IWFL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.53K	Buy	+100	New	+$5.21K	﹤0.01%	8927
2024 Q2	–	Sell	-33	Closed	-$1.19K	–	9790
2024 Q1	$1.19K	Buy	+33	New	+$1.1K	﹤0.01%	8197
2023 Q1	–	Sell	-919	Closed	-$14.9K	–	9966
2022 Q4	$14.9K	Hold	919	–	–	﹤0.01%	8038
2022 Q3	$15K	Buy	919 +765	+497%	+$15.1K	﹤0.01%	7803
2022 Q2	$3K	Buy	+154	New	+$3.37K	﹤0.01%	9329

UBS Group's IWFL Position: Q1 2026 in Review

UBS Group opened a new position in ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL) in Q1 2026: 100 shares worth $4.53K. The stake represents ﹤0.01% of the portfolio and ranks #8927 among its holdings. This is a return to the name: UBS Group previously reported a position in IWFL as recently as Q1 2024.

UBS Group first reported a position in IWFL in Q2 2022 and has held it in 5 quarters since. The position peaked at $15K in Q3 2022. 1 fund tracked by Wall St. Rank holds IWFL as of Q1 2026.

UBS Group held 100 shares of ETRACS 2x Leveraged US Growth Factor TR ETN worth $4.53K as of Q1 2026.
ETRACS 2x Leveraged US Growth Factor TR ETN was a new UBS Group position in Q1 2026.
ETRACS 2x Leveraged US Growth Factor TR ETN made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8927 holding.
UBS Group first reported a position in ETRACS 2x Leveraged US Growth Factor TR ETN in Q2 2022 and has held it in 5 quarters since.
UBS Group's ETRACS 2x Leveraged US Growth Factor TR ETN position peaked at $15K in Q3 2022.
1 fund tracked by Wall St. Rank held ETRACS 2x Leveraged US Growth Factor TR ETN as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.